NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
CrisisMilitaryStrikesPrivateFebruaryTrumpAdditionalAnnounceTimelineWinGovernmentOscarNewsDigestFundingIranianTariffsCourtBillionArrestedFacesElectionMajorCredit
CrisisMilitaryStrikesPrivateFebruaryTrumpAdditionalAnnounceTimelineWinGovernmentOscarNewsDigestFundingIranianTariffsCourtBillionArrestedFacesElectionMajorCredit
All Articles
Ralph Abraham, No. 2 official at CDC, abruptly steps down
STAT News
Published about 3 hours ago

Ralph Abraham, No. 2 official at CDC, abruptly steps down

STAT News · Feb 23, 2026 · Collected from RSS

Summary

The No. 2 official at the CDC has resigned, adding to the drama and chaos surrounding the agency's leadership.

Full Article

The drama and chaos surrounding the leadership of the Centers for Disease Control and Prevention have taken another twist, with the announcement Monday that the agency’s No. 2 official, Ralph Abraham, has resigned. A statement posted to the CDC’s website said Abraham, a former Louisiana surgeon general who was sworn in as the agency’s deputy secretary general only 2 1/2 months ago, stepped down to address “unforeseen family obligations.” The resignation is effective immediately. “It has been an honor to serve alongside the dedicated public health professionals at the CDC and to support the agency’s critical mission,” Abraham said in the statement. The CDC is theoretically being led by Jay Bhattacharya, who is also the director of the National Institutes of Health. Bhattacharya was named acting CDC director last week. But there is no expectation that the NIH director will be relocating to Atlanta or even spending significant amounts of time there. His predecessor, Jim O’Neill — who was also juggling two jobs, the other being the deputy health secretary — was also based in Washington. Abraham, who began the CDC job in early January after being sworn in in December, was actually physically present at the CDC’s headquarters in Atlanta. People familiar with the CDC’s operations believe the organization is being run by a group of political appointees in the office of the director, most of whom have no medical or public health experience. The CDC has only had a full-time director for four weeks in the current Trump administration. Susan Monarez, who briefly held that position, was fired late last August when she refused to agree to accept all vaccination policy recommendations from an advisory panel that health secretary Robert F. Kennedy Jr. stacked with anti-vaccine figures.


Share this story

Read Original at STAT News

Related Articles

STAT Newsabout 2 hours ago
STAT+: FDA unveils rules for bespoke gene therapies, predicting flood of rare disease applications

The FDA expects a flood of applications for a new "plausible mechanism pathway" for approval of bespoke gene-editing treatments.

STAT Newsabout 2 hours ago
STAT+: Medicare’s AI ‘modernization’ project, and the Ohio hospital antitrust battle

Would you trust AI to help you pick your Medicare plan?

STAT Newsabout 4 hours ago
STAT+: Novo’s next-gen obesity drug stumbles in Lilly comparison study

And other biotech news brought to you by The Readout

STAT Newsabout 4 hours ago
STAT+: People with intellectual and development disabilities have higher rates of anxiety, depression

And other health news from the Morning Rounds newsletter

STAT Newsabout 4 hours ago
STAT+: Pharmalittle: We’re reading about pharma lobbying, a disappointing Novo clinical trial, and much more

Pharmaceutical companies are boosting their spending on lobbying firms with connections to the White House

STAT Newsabout 5 hours ago
STAT+: Gossamer lung disease drug fails late-stage study, but company will still seek FDA approval

Gossamer Bio's drug for pulmonary arterial hypertension failed to achieve the primary endpoint of a Phase 3 clinical trial.